Major Analyst Actions Under Review: CRISPR Therapeutics AG … – Post Analyst
Post Analyst |
Major Analyst Actions Under Review: CRISPR Therapeutics AG …
Post Analyst The recently concluded session had traders exchanging CRISPR Therapeutics AG (NASDAQ:CRSP) high level. Roughly 2.03 million shares changed hands compared to the three-month volume average 0.64 million shares. The first trade took place at $37.76 and … Crispr Therapeutics (CRSP) Rating Increased to Strong-Buy at BidaskClub CRISPR Therapeutics scientific chief steps down |
